Recombinant ITGA4, ITGB7 (Etrolizumab Biosimilar) antibody

Catalog No. ABIN7666356

The Human Monoclonal anti-ITGA4, ITGB7 (Etrolizumab Biosimilar) antibody has been validated for . It is suitable to detect ITGA4, ITGB7 (Etrolizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant ITGA4, ITGB7 (Etrolizumab Biosimilar) antibody (ABIN7666356)

Target: ITGA4, ITGB7 (Etrolizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This ITGA4, ITGB7 (Etrolizumab Biosimilar) antibody is un-conjugated

Product Details anti-ITGA4, ITGB7 (Etrolizumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: α4β7 antibody (Etrolizumab biosimilar)

Purity: ≥95 % (SDS-PAGE&SEC)

Isotype: IgG1

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Storage Comment: Please store the product under the recommended conditions in the the instructions.

Target Details for ITGA4, ITGB7 (Etrolizumab Biosimilar)

Target: ITGA4, ITGB7 (Etrolizumab Biosimilar)

Alternative Name: Etrolizumab biosimilar

Target Type: Biosimilar

Background: Etrolizumab | ITGA4 | ITGB7

Gene ID: 3676

UniProt: P26010, P13612